Panor-D3 (Tab-in-Cap)
Pantoprazole + Domperidone + Cinitapride 3 Tablets in Capsule
| Composition | Each Capsule contains 3 tablets: Pantoprazole + Domperidone + Cinitapride |
|---|---|
| Dosage Form | Tab-in-Cap (Triple Layer) |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 10 Capsules |
| MRP | ₹ 1485 |
| Therapy | Gastroenterology — Triple-Action Tab-in-Cap |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Panor-D3 (Tab-in-Cap)
Panor-D3 is a premium tab-in-cap format with three different tablets inside a single capsule — Pantoprazole (PPI), Domperidone (prokinetic), and Cinitapride (5-HT4 agonist). Comprehensive acid suppression + dual prokinetic for severe refractory GERD.
Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Indications
- Severe refractory GERD
- GERD with severe motility issues
- Functional dyspepsia (resistant)
Mechanism of Action
Pantoprazole irreversibly inhibits gastric H+/K+ ATPase (proton pump) at parietal cell secretory canaliculi — markedly suppressing both basal and stimulated acid secretion. Lower CYP450 interaction profile than Omeprazole. Onset 1 hour, duration 24 hours. Domperidone is a peripheral D2 receptor antagonist enhancing upper GI motility, accelerating gastric emptying, and increasing LOS tone without crossing the blood-brain barrier. Cinitapride is additional 5-HT4 agonist prokinetic.
Dosage & Administration
Adults: 1 capsule once daily before breakfast.
Side Effects
Headache, diarrhoea, abdominal pain. Long-term: B12 deficiency, hypomagnesaemia, fracture risk (hip), C. difficile colitis, interstitial nephritis (rare). Hyperprolactinaemia, QT prolongation, somnolence.
Contraindications & Precautions
Hypersensitivity. Caution in severe hepatic impairment, osteoporosis (long-term), on clopidogrel (less interaction than omeprazole). Prolactinoma, QT prolongation.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Panor-D3 (Tab-in-Cap) is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Panor-D3 (Tab-in-Cap) used for?
Panor-D3 (Tab-in-Cap) contains Each Capsule contains 3 tablets: Pantoprazole + Domperidone + Cinitapride. Used as per the indications described above.
How should Panor-D3 (Tab-in-Cap) be taken?
As directed by your physician. Complete the prescribed course.
Is Panor-D3 (Tab-in-Cap) available for PCD pharma franchise?
Yes, Trumac Healthcare offers Panor-D3 (Tab-in-Cap) on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Panor-D3 (Tab-in-Cap) be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Panor-D3 (Tab-in-Cap) WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Panor-DSR Capsule — Pantoprazole 40 mg + Domperidone 30 mg (Sustained Release)
- Panor-CT Capsule — Pantoprazole 40 mg + Cinitapride 3 mg
- Panor-D 40 Tablet (10×10) — Pantoprazole 40 mg + Domperidone 10 mg